The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia

Citation
Mjv. Hoffer et al., The V73M mutation in the hepatic lipase gene is associated with elevated cholesterol levels in four Dutch pedigrees with familial combined hyperlipidemia, ATHEROSCLER, 151(2), 2000, pp. 443-450
Citations number
44
Categorie Soggetti
Cardiovascular & Respiratory Systems","Cardiovascular & Hematology Research
Journal title
ATHEROSCLEROSIS
ISSN journal
00219150 → ACNP
Volume
151
Issue
2
Year of publication
2000
Pages
443 - 450
Database
ISI
SICI code
0021-9150(200008)151:2<443:TVMITH>2.0.ZU;2-9
Abstract
Familial combined hyperlipidemia (FCHL) is a heritable lipid disorder chara cterized by multiple lipoprotein phenotypes within a single family. Previou sly, we have shown an increased incidence of mutations in the LPL gene whic h was associated with elevated levels of very low density lipoprotein (VLDL ) and decreased levels of high density lipoprotein among the families studi ed. Now, we report the results of our study on the hepatic lipase gene. We found the HL V73M variant to be present in four FCHL families. By means of a pedigree-based maximum log-likelihood method we analyzed the effect of th is variant on the lipid levels in these families. Carriers of the HL V73M v ariant revealed significantly higher levels of total cholesterol (P < 0.01) and apoB (P < 0.01). These findings show that the HL V73M mutant explains another part of the variability in the phenotype observed among FCHL family members, compared with mutations in the LPL gene. Family analysis shows th at in these FCHL families, carders of mutations in the LPL or HL genes have an increased risk for FCHL compared with their non-carrier relatives. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.